Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bank Capital Indonesia Tbk (BACA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Bank Capital Indonesia TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Bank Capital Indonesia Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Bank Capital Indonesia Tbk trades at Rp115 (market cap 2.31T, 463.2K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp164 (market cap 635.95B, 744.7K 24h volume). The key difference: Bank Capital Indonesia Tbk is far larger — about 3.6× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (744.7K versus 463.2K). Which is the better fit depends on your goals.

BACALABS
Market Cap
2.31T635.95B
Volume
463.2K744.7K
Lot
4.63K7.45K
Turnover
53.75M121.45M
Average Price
116.04163.09
Value
53.75M121.45M
Indicative Equilibrium Price
119163
Indicative Equilibrium Volume
40416

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BACA
View details
LABS
View details

About Bank Capital Indonesia Tbk

PT Bank Capital Indonesia (the company) was established under its original name of PT Bank Credit Lyonnais base on notarial deed No.139 of Mrs Siti Pertiwi, S.H, dated on Apr 20, 1989. The Company's articles of association has been amended several times, most recently by notarial deed No. 60 of Eliwati Tjitra, S.H., dated Jul 17, 2007, concerning among others, the change in the Company’s name, Anggaran Dasar and public offering.

Read more on BACA

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS